Data Code Sets

Related Pages
On This Page
email_03Get Email Updates

To receive email updates about this page, enter your email address:

What's this?
CVX
CVX Mapped to Vaccine Groups
CVX Mapped to VIS
MVX
Product Name Mapped to CVX/MVX
NDC Crosswalk Tables
VIS Barcode Lookup Table
VIS to Current URL Table
CPT Mapped to CVX
COVID-19 Vaccine Related Codes

For more information on background and concepts see Understanding the Rules for Creating CVX and MVX Codes [5 pages]

View archived 2015 Edition Versioned Codes

More ways to access CDC’s Vaccine Code Set information: Code Set Viewpoint search/browse website and REST Web Service

COVID-19 Vaccine Related Codes

Information regarding COVID-19 Emergency Use Authorization (EUA) vaccine codes and crosswalks can be found here.

Registered users can now access COVID-19 vaccine lot numbers and expiration dates provided to CDC by the vaccine manufacturer. COVID-19 Vaccine Lot Number and Expiration Date Tool

Seasonal Influenza Codes and Crosswalk

This new format includes all seasonal influenza vaccines for the 2022/2023 season in a single Excel crosswalk table that provides the CVX, MVX, NDC Unit of Sale, NDC Unit of Use, and CPT (*)  codes for each vaccine.

(*) Please note that the CPT codes shown for each vaccine crosswalk are not mapped to the NDC codes, but are mapped to the CVX codes shown.  These are reference CPT codes for vaccine categorization and are not intended to represent billable codes.

Download the Seasonal Influenza Crosswalk table

Influenza Vaccines for Season 2021/2022 (Northern Hemisphere)
CVX Code CVX Short Description Sale Proprietary Name Sale Labeler MVX Code Unit of Sale NDC11 Unit of Use NDC11 Presentation CPT Code CPT Description
149 influenza, live, intranasal, quadrivalent FluMist Quadrivalent MedImmune, LLC MED 66019-309-10 66019-309-01 APPLICATOR .2 mL 90672 Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use
150 influenza, injectable, quadrivalent, preservative free Flulaval Quadrivalent ID Biomedical Corporation of Quebec IDB 19515-0808-52 19515-0808-41 SYRINGE, .5 mL 90686 Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use
150 influenza, injectable, quadrivalent, preservative free FLUZONE QUADRIVALENT Sanofi Pasteur Inc. PMC 49281-0422-10 49281-0422-58 VIAL, .5 mL, SINGLE-DOSE 90686 Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use
150 influenza, injectable, quadrivalent, preservative free FLUZONE QUADRIVALENT Sanofi Pasteur Inc. PMC 49281-0422-50 49281-0422-88 SYRINGE, .5 mL 90686 Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use
150 influenza, injectable, quadrivalent, preservative free FLUARIX QUADRIVALENT GlaxoSmithKline Biologicals SA SKB 58160-0890-52 58160-0890-41 SYRINGE, .5 mL 90686 Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use
150 Influenza, injectable, quadrivalent, preservative free Afluria Quadrivalent Seqirus PTY LTD. SEQ 33332-0322-03 33332-0322-04 SYRINGE, .5 mL 90686 Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use
158 influenza, injectable, quadrivalent FLUZONE QUADRIVALENT Sanofi Pasteur Inc. PMC 49281-0637-15 49281-0637-78 VIAL, 5 mL, MULTI-DOSE 90687 Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use
90688 Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use
158 influenza, injectable, quadrivalent, contains preservative Afluria Quadrivalent Seqirus PTY LTD. SEQ 33332-0422-10 33332-0422-11 VIAL, 5 mL, MULTI-DOSE 90687 Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use
90688 Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use
171 Influenza, injectable, MDCK, preservative free, quadrivalent FLUCELVAX QUADRIVALENT Seqirus Inc. SEQ 70461-0322-03 70461-0322-04 SYRINGE, .5 mL 90674 Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use
185 influenza, recombinant, quadrivalent,injectable, preservative free Flublok Quadrivalent Northern Hemisphere Sanofi Pasteur Inc. PMC 49281-0722-10 49281-0722-88 SYRINGE, .5 mL 90682 Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use
186 Influenza, injectable, MDCK, quadrivalent, preservative FLUCELVAX QUADRIVALENT Seqirus Inc. SEQ 70461-0422-10 70461-0422-11 VIAL, 5 mL, MULTI-DOSE 90756 Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use
197 influenza, high-dose, quadrivalent FLUZONE High-Dose Quadrivalent Northern Hemisphere Sanofi Pasteur Inc. PMC 49281-0122-65 49281-0122-88 SYRINGE, .7 mL 90662 Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use
205 Influenza vaccine, quadrivalent, adjuvanted FLUAD QUADRIVALENT Seqirus, Inc. SEQ 70461-0122-03 70461-0122-04 SYRINGE, .5 mL 90694 Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use
Southern Hemisphere 2022 Influenza Season
CVX Code CVX Short Description Sale Proprietary Name Sale Labeler MVX Code Unit of Sale NDC11 Unit of Use NDC11 Presentation CPT Code CPT Description
200 influenza, Southern Hemisphere, pediatric, preservative free FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE Sanofi Pasteur Inc. PMC NA NA SYRINGE, 0.25 mL NA NA
201 influenza, Southern Hemisphere, preservative free FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE Sanofi Pasteur Inc. PMC 49281-0322-50 49281-0322-88 SYRINGE, 0.5 mL NA NA
202 influenza, Southern Hemisphere, quadrivalent, with preservative FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE Sanofi Pasteur Inc. PMC 49281-0339-15 49281-0339-78 VIAL, MULTI-DOSE, 5 mL NA NA
Top of Page
Page last reviewed: June 7, 2019
Content source: National Center for Immunization and Respiratory Diseases